Bio printing
Could be the New Solution to Organ Transplantation
3D technology is proving
that the future looks quite different, with tissue engineering taking center
stage, anticipating a possible future where organ transplants will not be
needed to survive. One
of the most well-known tissue engineering companies is San Diego-based Organovo.
It has been actively developing a line of human tissues for use in medical
research and drug discovery for years.
The company, one of the first
big players in bioprinting, was founded in 2007 by Keith Murphy and Gabor
Forgacs with a focus on developing in vivo liver tissues to treat a range of
rare, life-threatening diseases, for which there are few current treatment
options other than organ transplantation. Organovo’s ultimate goal in
developing their liver therapeutic tissue is to delay or reduce the need for a
transplant. The firm is also trying to harness their foundational ability to
characterize specialized human cells and to 3D bioprint functional tissues to
create novel in vitro toxicology and liver disease modeling platforms.
International Conference on Organ Donation and Transplantation Science
July 15-16, 2019 Sydney, Australia
Please visit: https://world.geneticconferences.com/
#transplantation
#organdonation #donatelife #donar #kidney #lung #heart
#transplant
No comments:
Post a Comment